当前位置:首页 - 行情中心 - 实朴检测(301228) - 财务分析 - 利润表

实朴检测

(301228)

  

流通市值:32.80亿  总市值:32.87亿
流通股本:1.20亿   总股本:1.20亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入94,374,726.28442,106,672.28307,081,521.91198,975,380.95
  营业收入94,374,726.28442,106,672.28307,081,521.91198,975,380.95
二、营业总成本99,410,901.07459,575,369.76318,267,329.92208,074,276.07
  营业成本66,486,377.18320,311,210.87219,643,074.19142,061,164.46
  税金及附加182,878.51,450,783.07722,314.78442,483.82
  销售费用12,460,007.0654,033,037.4638,503,999.0325,064,318.01
  管理费用11,786,465.1250,639,853.4834,661,400.2223,210,604.5
  研发费用8,042,097.8431,598,975.5623,819,846.1516,738,323.32
  财务费用453,075.371,541,509.32916,695.55557,381.96
  其中:利息费用179,891.131,740,916.921,313,563.95908,934.45
  其中:利息收入131,758.131,751,724.66794,867.421,077,611.21
三、其他经营收益
  加:公允价值变动收益-27,649.4-255,337.91-85,652.66-139,546.14
  加:投资收益-263,520.31-1,610,175.87-661,584.67857,705.62
  资产处置收益102,965.553,855.14-19,323.3-60,412.59
  资产减值损失(新)388,690.82-2,478,039.93-149,513.98-591,330.47
  信用减值损失(新)-3,189,711.64-44,870,218.49-35,278,016.01-22,297,959.96
  其他收益457,658.272,683,375.661,396,303.26542,311.5
四、营业利润-7,567,741.55-63,945,238.88-45,983,595.37-30,788,127.16
  加:营业外收入1,412.371,057,180.86822,251.84551,755.11
  减:营业外支出1,825,961.891,303,039.65661,704.01584,710.4
五、利润总额-9,392,291.07-64,191,097.67-45,823,047.54-30,821,082.45
  减:所得税费用-1,967,988.99-8,673,487.64-8,734,967.81-5,678,251.9
六、净利润-7,424,302.08-55,517,610.03-37,088,079.73-25,142,830.55
(一)按经营持续性分类
  持续经营净利润-7,424,302.08-55,517,610.03-37,088,079.73-25,142,830.55
(二)按所有权归属分类
  归属于母公司股东的净利润-8,085,944.74-65,790,026.68-37,730,072.76-26,332,520.93
  少数股东损益661,642.6610,272,416.65641,993.031,189,690.38
  扣除非经常损益后的净利润-6,946,844.08-67,024,458.91-39,423,917.07-27,353,645.25
七、每股收益
  (一)基本每股收益-0.07-0.56-0.31-0.23
  (二)稀释每股收益-0.07-0.56-0.31-0.23
九、综合收益总额-7,424,302.08-55,517,610.03-37,088,079.73-25,142,830.55
  归属于母公司股东的综合收益总额-8,085,944.74-65,790,026.68-37,730,072.76-26,332,520.93
  归属于少数股东的综合收益总额661,642.6610,272,416.65641,993.031,189,690.38
公告日期2025-04-242025-04-242024-10-252024-08-29
审计意见(境内)标准无保留意见
TOP↑